Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Community Based Intervention01:30

Community Based Intervention

620
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
620
Drug Dependence01:17

Drug Dependence

1.9K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.9K
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.6K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.6K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

6.7K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
6.7K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation Evaluation of a Multicomponent Intervention to Address the Infectious Disease and Overdose Syndemic Among People Who Use Drugs in Rural Settings.

Journal of public health management and practice : JPHMP·2026
Same author

Benzodiazepine Tapering: Joint Guidelines From the American Society of Addiction Medicine.

American family physician·2026
Same author

Integrating Medicine and Public Health Through Health Professions Education at a School of Medicine and Public Health.

WMJ : official publication of the State Medical Society of Wisconsin·2026
Same author

Building Stronger Communities Through Addiction Care Innovation, Research, Education, and Advocacy-Overview and Proceedings of the AMERSA 2025 Conference.

Substance use & addiction journal·2026
Same author

Low-threshold Buprenorphine: Proposing the Ideal Service Model to Engage People With Severe Opioid Use Disorder.

Journal of addiction medicine·2026
Same author

Detecting stigmatizing language in clinical notes with large language models for addiction care.

npj health systems·2026

Related Experiment Video

Updated: May 4, 2026

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K

A novel community-based buprenorphine program: client description and initial outcomes.

Amy M Daniels1, Elizabeth Salisbury-Afshar, Adam Hoffberg

  • 1From the Autism Speaks (AMD), New York; and Johns Hopkins Bloomberg School of Public Health (ES-A, DA), Behavioral Health Leadership Institute (AH, DA), and Johns Hopkins University, Johns Hopkins Bayview Medical Center (MIF), Baltimore, MD.

Journal of Addiction Medicine
|January 8, 2014
PubMed
Summary
This summary is machine-generated.

Buprenorphine treatment for opiate dependence in a community recovery center showed high opiate abstinence and adherence. Nearly half of clients transitioned to primary care, demonstrating successful integration of this addiction treatment.

More Related Videos

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

1.8K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

2.3K

Related Experiment Videos

Last Updated: May 4, 2026

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

1.8K
A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence
08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

2.3K

Area of Science:

  • Addiction Medicine
  • Community Health
  • Pharmacotherapy

Background:

  • Opioid dependence remains a significant public health challenge.
  • Community-based recovery centers offer accessible addiction treatment.
  • Integrating medication-assisted treatment like buprenorphine is crucial.

Purpose of the Study:

  • To describe the characteristics of clients in a community-based buprenorphine program.
  • To evaluate initial treatment outcomes, including opiate abstinence and treatment adherence.
  • To assess the feasibility of transitioning clients to primary care.

Main Methods:

  • Retrospective descriptive study analyzing records of 78 clients from July 2010 to August 2011.
  • Data abstraction included demographics, health, substance use, and treatment history.
  • Weekly urine toxicology reports monitored opiate and buprenorphine use.

Main Results:

  • High rates of opiate abstinence (83%) and buprenorphine compliance (95%) were observed.
  • Adjusted analyses considering missing data showed 60% opiate abstinence and 74% compliance.
  • 49% of clients were successfully transitioned to buprenorphine treatment in primary care.

Conclusions:

  • Buprenorphine treatment can be effectively integrated into community-based recovery centers.
  • The program demonstrated high patient adherence and positive treatment outcomes.
  • Successful transition to primary care indicates a sustainable model for opioid dependence treatment.